G40702WU

Summary
GlyTouCan ID
G40702WU
IUPAC Condensed
Man(a1-2)Man(a1-2)Man(a1-3)[Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b1-
Motifs
N-Glycan high mannose
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
1720.59
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
CarbBank
1776 1777 1778 1779 3890 3891 5995 7683 7684 7686 7687 7688 13812 14596 20516 22613 26138 31277 33201 36539 37694 38468 43567
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
UGGT1 (UGCGL1) UDP-Glc
G40702WU
MTX
G81356NS
MTX
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
UGGT1 (UGCGL1) UDP-Glc
G40702WU
MTX
G81356NS
MTX
KEGG BRITE Database
GALAXY
Glucose Units
ODS
4.9
Amide
9
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:a-dman-HEX-1:5
8b:a-dman-HEX-1:5
9b:a-dman-HEX-1:5
10b:a-dman-HEX-1:5
11b:a-dman-HEX-1:5
12b:a-dman-HEX-1:5
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:6o(2+1)7d
7:7o(2+1)8d
8:5o(6+1)9d
9:9o(3+1)10d
10:9o(6+1)11d
11:11o(2+1)12d
WURCS
WURCS=2.0/3,10,9/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5]/1-1-2-3-3-3-3-3-3-3/a4-b1_b4-c1_c3-d1_c6-g1_d2-e1_e2-f1_g3-h1_g6-i1_i2-j1
Literature
Displaying entries 1 - 10 of 22 in total
PubMed ID Title First Author Publication Date Source
33737529 Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures Suzuki Noriko 2021-03-18
  • GlyGen
34834161 Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity Cruz E 2021 Oct 20
  • GlyGen
  • PubChem
32879488 Shared structural mechanisms of general anaesthetics and benzodiazepines Kim JJ 2020 Sep 02
  • PubChem
31097697 Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage Simonich CA 2019 May 16
  • PubChem
19270371 Strategic Glycan Elution Map for the Production of Human-TypeN-Linked Oligosaccharides: The Case of Hen Egg Yolk and White SUMIYOSHI W 2009 Mar 23
  • GlyGen
12110688 Structures of the Complexes of a Potent Anti-HIV Protein Cyanovirin-N and High Mannose Oligosaccharides Botos I 2002 Sep 13
  • PubChem
11469797 The widespread effect of beta 1,4-galactosyltransferase on N-glycan processing Fukuta K 2001 Aug 01
  • GlyGen
  • PubChem
10988252 Characterization of the carbohydrate chains of the secreted form of the human epidermal growth factor receptor Stroop CJ 2000 Sep
  • GlyGen
  • PubChem
10929010 N-glycan patterns of human transferrin produced in Trichoplusia ni insect cells: effects of mammalian galactosyltransferase Ailor E 2000 Aug
  • GlyGen
  • PubChem
9952469 Characterization of N-Glycans from Arabidopsis. Application to a Fucose-Deficient Mutant1 Rayon C 1999 Feb 01
  • GlyGen

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.3.0

Last updated: August 4, 2025